Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Bourdages

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Plos One|February 6, 2014
Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseasesPascale Blais Lecours, David Marsolais, Yvon Cormier, et al.
Inflammatory Bowel Diseases|December 12, 2018
IBDoc Canadian User Performance EvaluationAlice C Moore, Vivian W Huang, Raymond Bourdages, et al.
Journal of Medical Economics|August 24, 2017
Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulationSean Stern, Alexandra J Ward, Catherine Saint-Laurent Thibault, et al.
Gastroenterology|November 26, 2013
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's diseaseBrian G Feagan, John W D McDonald, Remo Panaccione, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Plos One|February 6, 2014
Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseasesPascale Blais Lecours, David Marsolais, Yvon Cormier, et al.
Inflammatory Bowel Diseases|December 12, 2018
IBDoc Canadian User Performance EvaluationAlice C Moore, Vivian W Huang, Raymond Bourdages, et al.
Journal of Medical Economics|August 24, 2017
Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulationSean Stern, Alexandra J Ward, Catherine Saint-Laurent Thibault, et al.
Gastroenterology|November 26, 2013
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's diseaseBrian G Feagan, John W D McDonald, Remo Panaccione, et al.
Pageof 1